Know Labs Corporation - רווח נקי למניה ב-12 החודשים האחרונים KNW

The annual EPS TTM growth for Know Labs, Inc. (KNW) demonstrates current volatility, with the indicator reaching 13.30. This trend reflects the scaling of Bio-RFID for B2B licensing within the glucose monitoring sector. The transition toward system commercialization is rendering cash flows unstable. A lack of operational inertia and the sensor development stage dictate the company's current net capital expenditure regime.

This indicator reflects the dynamics of net income per share compared to the same period last year. By analyzing the rolling annual growth of net income per share, an investor assesses the real efficiency of capital generation. The calculation is based on the difference in TTM values, which neutralizes reporting seasonality. For Know Labs, Inc. (KNW), the negative trend highlights a stage of active cash burn. This is critical while awaiting FDA certification and competing with medtech behemoths.